Semaphorin 3F expression is reduced in pregnancy complicated by preeclampsia. An observational clinical study.
BACKGROUND AND OBJECTIVE:Preeclampsia is a systemic disorder, affecting 2-10% of pregnancies, characterized by a deregulated pro- and anti-angiogenic balance. Semaphorin 3F is an angiogenesis inhibitor. We aimed to investigate whether semaphorin 3F expression is modulated in preeclampsia. DESIGN, SE...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2017-01-01
|
| シリーズ: | PLoS ONE |
| オンライン・アクセス: | http://europepmc.org/articles/PMC5370113?pdf=render |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
